HomeCNSP • NASDAQ
add
CNS Pharmaceuticals Inc
Previous close
$1.11
Day range
$1.08 - $1.15
Year range
$1.00 - $137.50
Market cap
3.16M USD
Avg Volume
3.34M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.54M | -28.05% |
Net income | -3.54M | 28.13% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.54M | 28.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 815.23K | -84.05% |
Total assets | 1.66M | -77.60% |
Total liabilities | 6.09M | 55.28% |
Total equity | -4.43M | — |
Shares outstanding | 237.04K | — |
Price to book | -0.05 | — |
Return on assets | -527.24% | — |
Return on capital | 212.30% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -3.54M | 28.13% |
Cash from operations | -3.19M | 33.84% |
Cash from investing | — | — |
Cash from financing | 3.46M | 2,975.33% |
Net change in cash | 266.50K | 105.39% |
Free cash flow | -1.71M | 43.26% |
About
Founded
2017
Headquarters
Website
Employees
3